What MD Group does

MD Group (legally MDE Services Group Limited) is a UK-headquartered clinical trial services company founded in 2002 that provides patient-centric support services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company delivers an integrated portfolio of services spanning patient travel and accommodation, decentralized clinical services (mobile health nursing and in-home procedures), patient payments and reimbursements, dedicated navigator coordination, clinical equipment logistics through its Horreum brand, and clinical research staffing through its Seacole Health brand. Its operations are organized across wholly-owned subsidiaries in the UK, US, Ireland, France, Netherlands, Singapore, Hong Kong, and Brazil, with active trial delivery reach extending into additional markets including Australia and India.

The company's underlying technology stack is anchored by the primarius digital platform—a patient mobile app, site portal, and client portal that digitally coordinates reimbursements, travel, and family support requests. This is complemented by Horreum's express medical supply distribution network for decentralized and hybrid trial logistics, and Seacole Health's flexible staffing platform for placing healthcare professionals into clinical research roles. The company reports a 99% patient satisfaction rate and holds FDA 21 CFR Part 11, EU GDPR, and GCP/ISO 9001-aligned compliance certifications.

MD Group generates revenue through contracted professional services and managed services engagements with enterprise pharma sponsors and CROs on a study-by-study basis. Its go-to-market is enterprise field sales, supplemented by event-driven business development at major industry conferences such as SCOPE Summit. Pricing is not publicly disclosed and is negotiated per project based on scope. The company's customer base includes biotech and pharmaceutical sponsors operating in rare disease, pediatric, cell and gene therapy, and increasingly diabetes/obesity therapeutic areas—with named clients including Rocket Pharmaceuticals and PTC Therapeutics. The business is founder-influenced, privately held, and has not disclosed external funding rounds.

Name

MD Group

Legal name

MDE Services Group Limited

Website

https://mdgroup.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

MD Group is a UK-headquartered clinical trial services firm that delivers patient support services—including travel, mobile health visits, payments, navigator coordination, logistics, and staffing—to pharmaceutical sponsors and CROs running decentralized and hybrid clinical trials globally.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Support Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Clinical trial services
• Patient support services
• Decentralized clinical trials
• Patient travel logistics
• Clinical research staffing

Headquarters

HQ city

Bracknell

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Patient Support Services: MD Group generates revenue by providing contracted patient support services to clinical trial sponsors and CROs, including patient travel, accommodation, mobile health visits, navigator coordination, and expense reimbursement management. Services are delivered on a project basis aligned with clinical trial protocols.
2. Decentralized Clinical Services: Revenue from delivering in-home clinical procedures, mobile nursing, and hybrid trial support services. Healthcare providers are dispatched to patient homes to conduct study-related activities, reducing the need for frequent site visits.
3. Clinical Logistics and Equipment: Global clinical equipment logistics through Horreum, providing medical supply delivery to trial sites and patient homes, with express delivery services for decentralized trials.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

MD Group provides end-to-end patient support and decentralized clinical trial services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company manages patient travel and accommodation, mobile health visits, patient payments and reimbursements, dedicated patient navigator coordination, global clinical equipment logistics, and clinical research staffing. Services are delivered on a contracted, study-by-study basis across multiple geographies including the UK, US, Europe, Asia-Pacific, and Latin America.

Product overview

MD Group operates as a clinical trial services company offering an integrated ecosystem of patient-first solutions. The core service portfolio includes Patient Travel, Decentralized Clinical Services (Mobile Health), Patient Payments, Patient Coordination (Navigator Services), Clinical Logistics, and Clinical Staffing. These services are supported by digital platforms and sub-brands: primarius (a digital ecosystem with patient mobile app, site portal, and client portal for managing reimbursements, travel, and support requests), Seacole Health (a staffing agency for healthcare professionals), and Horreum (a medical supply chain and distribution service). The company combines these capabilities to deliver end-to-end clinical trial support that reduces patient burden and improves retention.

Differentiator

Problem solved

Functional benefit

Brands

• primarius: Patient mobile app that puts patients at the heart of clinical trials, offering expense claims, reimbursements, travel management, and family support requests.
• Seacole Health
• Horreum
• mdgroup forest
• mdgroup live
• mdtalk
• mdeducational foundation

Products and services

• Patient Travel Services Arranges and manages patient travel, accommodation, and relocation services to facilitate participation in clinical trials. Targeted at pharmaceutical sponsors and CROs running global clinical studies with patients requiring logistical support.
• Decentralized Clinical Services Provides in-home clinical procedures, mobile nursing, and remote patient monitoring to reduce the need for frequent site visits in decentralized and hybrid clinical trials. Designed for sponsors seeking to expand geographic reach and reduce site burden.
• Patient Payments Manages patient stipends, reimbursements, and financial support services throughout the clinical trial journey, including multi-country and multi-currency disbursements. Used by sponsors and CROs to reduce administrative burden on sites and improve patient participation.
• Patient Coordination (Navigator Services) Provides dedicated patient navigators to guide patients and families through the clinical trial process as single points of contact, offering personalized coordination across travel, payments, and clinical visits. Targeted at sponsors of complex trials in rare disease and pediatric populations.
• Clinical Logistics Offers global clinical equipment logistics including express delivery and supply chain management for decentralised and hybrid trials. Delivered via the Horreum medical distribution center with overnight or 2-3 day delivery depending on location.
• Seacole Health (Clinical Staffing Agency) A staffing agency placing healthcare professionals including phlebotomists, research coordinators, nurses, and doctors into clinical research roles. Provides flexible staffing for mobile health, on-site, and research roles to hospitals, CROs, and clinical trial sponsors.
• Horreum Medical Distribution Express medical supply delivery service to decentralized and hybrid clinical trials worldwide, with overnight or 2-3 day delivery depending on location. Mitigates supply chain issues for post-pandemic decentralized trial environments.
• primarius Digital Platform A comprehensive digital ecosystem comprising a patient mobile app, site portal, and client portal that connects patients, sites, and clients. Enables expense claims, reimbursements, travel arrangements, and family support requests throughout clinical trial participation.
• On-Demand Patient Concierge Services Patient concierge and travel services designed to reduce the practical and logistical burden of trial participation, providing tailored support services on demand for clinical trial participants and their families.

Quantifiable outcome

• 99% patient satisfaction rate
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• PTC TherapeuticscoreStrategic or Co-development Partner · 1 April 2026MD Group partnered with PTC Therapeutics, a global biopharmaceutical company, to host a breakout session at SCOPE Summit 2026 focused on improving study confidence through patient support services. The collaboration centered on demonstrating the impact of patient support services on clinical trial outcomes and sponsor confidence.
• Rocket PharmaceuticalscoreStrategic or Co-development Partner · 1 January 2019MD Group partnered with Rocket Pharmaceuticals to support a Phase I/II clinical study investigating a gene therapy for pediatric patients with Leukocyte Adhesion Deficiency-I (LAD-I), a rare disease. MD Group provided global patient support including travel logistics, accommodation, and home health visits to enable patient participation across multiple countries including India.
• SCOPE Summit (Clinical Research Community)minorGTM or Marketing PartnerMD Group has been an active sponsor and exhibitor at SCOPE Summit annually (2022, 2023, 2026), using the conference to build relationships with sponsors and CROs, share thought leadership, and showcase case studies. SCOPE serves as a key marketing and business development channel.
• Seacole HealthcoreOthersSeacole Health is an MD Group company launched in 2021 as a standalone staffing agency for healthcare and research professionals in clinical trials. Seacole provides flexible staffing solutions including phlebotomists, research coordinators, and mobile health nurses to MD Group's clinical trial operations, as well as to external clients like hospitals and CROs.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PCM Trials: A leading provider of global patient concierge and reimbursement services for clinical trials, with a strong presence in decentralized and hybrid trial support. Closely overlaps with MD Group's Patient Travel, Payments, and Navigator offerings.
• Greenphire: Specializes in patient reimbursement, stipend management (ClinCard), and travel/financial workflow automation for clinical trials. Directly comparable to MD Group's Patient Payments and Travel services and a competitor in the same procurement decisions.

Broad incumbents

• IQVIA (Decentralized & Patient Solutions): The world's largest CRO offers integrated DCT, home health, and patient engagement services across thousands of trials. Competes with MD Group in sponsors' vendor selections and increasingly offers bundled solutions that can substitute MD Group's scope.
• ICON plc (including PRA Health): Major global CRO with growing DCT and patient-centric service lines post-PRA merger. Competes with MD Group both directly (DCT enablement) and indirectly via end-to-end CRO bundle pressure on mid-sized specialty vendors.
• Syneos Health: Large clinical and commercial services provider with decentralized clinical trial capabilities and patient engagement offerings. Overlaps with MD Group's mobile health and patient navigation services as part of broader sponsor RFPs.

Emerging players

• Curebase: A DCT-focused technology and services provider enabling decentralized and hybrid trials via a virtual research site model. Overlaps with MD Group's decentralized service line but with greater emphasis on virtual site operations.
• Medable: Provides an eCOA, eConsent, telehealth, and DCT enablement technology platform used by sponsors and CROs. Comparable to the primarius patient app and adjacent to MD Group's broader service layer.
• Clariness: Patient recruitment and feasibility vendor for clinical trials, with particular focus on patient-centric recruitment funnels. Directly comparable to MD Group's patient recruitment and retention enablement services.
• Science 37: Decentralized clinical trial company providing mobile nursing, telemedicine, and remote data capture for sponsors running fully decentralized studies. Competes with MD Group's decentralized clinical services and mobile health nursing offerings.

Regional players

• Clinipace Worldwide: Mid-sized CRO with therapeutic focus areas including rare disease; offers patient recruitment and clinical management services. A mid-tier competitor to MD Group especially in North America and Europe for rare disease sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mdgroupintl
• LinkedInlinkedin.com/company/md-events
• Facebookfacebook.com/mdgroupintl

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MD Group